Trial NCT04892459
Publication Li J, Nat. Med., 2022
Primary outcome on the report: 1) adverse reactions within 28 days after the vaccination; 2) geometric mean titres of neutralizing antibodies against live SARS-CoV-2 virus at 14 days after the booster vaccination

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.